| Serial Number | 99644627 |
| Word Mark | EVE16 |
| Filing Date | Tuesday, February 10, 2026 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, June 10, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Pseudo Mark | EVE SIXTEEN |
| Goods and Services | Research and development in the field of immunotherapy, cell therapy, gene therapy, and immune cell engineering; biomedical research relating to engineered immune receptors, antibody-dependent cellular cytotoxicity platforms, and targeted immune activation technologies |
| Pseudo Mark | EVE ONE SIX |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 10, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, September 1, 2022 |
| First Use In Commerce Date | Thursday, June 1, 2023 |
| Party Name | InnDura Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CAMBRIDGE, MA 02139 US |
| Event Date | Event Description |
| Tuesday, February 10, 2026 | NEW APPLICATION ENTERED |
| Tuesday, February 10, 2026 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, June 9, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 10, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, June 10, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 10, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, June 10, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |